GlassScriptPhysician profile
Amit I Shah
NPI 1407850449
$29,362.68
in general payments reported to CMS, 2019-2025
90 companies · $5,580 in 2025
The $5,580 reported for 2025 was more than what 75% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,554 · 2020: $2,797 · 2021: $3,621 · 2022: $3,791 · 2023: $5,492 · 2024: $4,528 · 2025: $5,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,790.60 |
| Education | $809.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,700.74 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Janssen Biotech, INC. | $2,026.75 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Celgene Corporation | $1,801.29 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| E.R. Squibb & Sons, L.L.C. | $1,785.98 | 2019-2025 | Opdivo, Opdualag |
| Pfizer INC. | $1,430.51 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,235.53 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| Novartis Pharmaceuticals Corporation | $1,228.87 | 2019-2025 | |
| Incyte Corporation | $1,083.27 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Amgen INC. | $965.47 | 2019-2023 | Lumakras, Nplate, Vectibix |
| Bayer Healthcare Pharmaceuticals INC. | $925.71 | 2019-2025 | |
| Lilly USA, LLC | $907.02 | 2019-2024 | Jaypirca, Verzenio, Retevmo |
| Seagen INC. | $897.44 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Genentech USA, INC. | $774.05 | 2019-2025 | Tecentriq, Alecensa, Venclexta |
| Daiichi Sankyo INC. | $608.82 | 2021-2025 | Enhertu, Datroway |
| Eisai INC. | $607.45 | 2019-2025 |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $533.87 | 2019-2025 | Alunbrig, Iclusig, Fruzaqla |
| Genzyme Corporation | $523.83 | 2019-2025 | |
| Astellas Pharma US INC | $484.09 | 2019-2025 | Vyloy, Padcev, Xtandi |
| Glaxosmithkline, LLC. | $441.44 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Sobi, INC | $439.75 | 2022-2025 | |
| Gilead Sciences, INC. | $396.55 | 2021-2025 | Trodelvy |
| Rigel Pharmaceuticals, INC. | $375.83 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Alexion Pharmaceuticals, INC. | $368.02 | 2019-2025 | Ultomiris |
| Abbvie INC. | $335.65 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $295.57 | 2021-2025 | Onivyde |
| Array Biopharma INC | $279.93 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Pharmacyclics LLC, An Abbvie Company | $266.81 | 2019-2023 | Imbruvica |
| Stemline Therapeutics INC. | $240.79 | 2023-2025 | Orserdu |
| Alnylam Pharmaceuticals INC. | $205.93 | 2022-2024 | Amvuttra, Onpattro, Givlaari |
| Foundation Medicine, INC. | $201.50 | 2020-2023 | |
| Beigene USA, INC. | $194.90 | 2020-2023 | Brukinsa |
| Dova Pharmaceuticals | $186.32 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $184.82 | 2019-2025 | Libtayo |
| Karyopharm Therapeutics INC. | $174.56 | 2020-2025 | Xpovio |
| Asd Specialty Healthcare, LLC | $174.46 | 2019 | |
| Aveo Pharmaceuticals, INC. | $160.90 | 2021-2025 | Fotivda |
| Adaptive Biotechnologies Corporation | $154.72 | 2019-2025 | Clonoseq |
| Genmab U.S., INC. | $150.43 | 2024-2025 | Epkinly |
| Exelixis INC. | $142.64 | 2024-2025 | Cabometyx |
| Emd Serono, INC. | $139.98 | 2019-2024 | Bavencio |
| Geron Corporation | $138.99 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $135.82 | 2021-2025 | Poteligeo |
| Myriad Genetic Laboratories, INC. | $135.07 | 2021-2023 | Myrisk |
| Taiho Oncology, INC. | $133.60 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $130.78 | 2020-2025 | |
| Tersera Therapeutics LLC | $126.94 | 2022-2025 | Zoladex |
| Radius Health, INC. | $125.39 | 2023 | Tymlos |
| Agios Pharmaceuticals, INC. | $124.29 | 2023-2024 | Pyrukynd |
| Deciphera Pharmaceuticals INC. | $118.52 | 2021-2024 | Qinlock |
| Adc Therapeutics America, INC. | $115.39 | 2022-2025 | |
| Puma Biotechnology, INC. | $113.05 | 2020-2022 | |
| Kite Pharma, INC. | $108.05 | 2021-2025 | Yescarta |
| Sumitomo Pharma America, INC. | $103.36 | 2023-2025 | Orgovyx |
| Clovis Oncology, INC. | $100.58 | 2019-2020 | |
| Pharmacosmos Therapeutics INC. | $100.55 | 2020-2025 | Monoferric |
| Apellis Pharmaceuticals, INC. | $100.50 | 2022-2024 | Empaveli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.11 | 2021-2024 | Gilotrif |
| Morphosys, US INC. | $96.61 | 2021-2024 | Monjuvi |
| Pharmaessentia USA Corporation | $93.55 | 2023-2025 | Besremi |
| Dendreon Pharmaceuticals LLC | $74.76 | 2020-2025 | Provenge |
| Blueprint Medicines Corporation | $74.52 | 2022-2025 | Ayvakit |
| Immunogen, INC. | $71.85 | 2023 | Elahere |
| Myovant Sciences INC. | $60.88 | 2021-2022 | |
| Verastem, INC. | $58.28 | 2019 | |
| Electromed, INC. | $56.51 | 2025 | Smartvest |
| Helsinn Therapeutics (U.S.), INC. | $53.15 | 2019-2023 | Valchlor |
| Acrotech Biopharma INC. | $50.58 | 2023-2024 | Beleodaq |
| Boston Scientific Corporation | $48.00 | 2019 | |
| Cti Biopharma Corp. | $44.72 | 2022-2023 | Vonjo |
| Mirati Therapeutics, INC. | $38.37 | 2024 | Krazati |
| Genentech, INC. | $38.00 | 2019 | |
| Recordati_rare_diseases_inc. | $36.23 | 2025 | Enjaymo, Sylvant |
| Inogen, INC. | $35.34 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Immunocore Limited | $32.99 | 2025 | Kimmtrak |
| G1 Therapeutics, INC. | $32.88 | 2022 | |
| Legend Biotech USA INC. | $32.01 | 2025 | Carvykti |
| Corcept Therapeutics | $28.53 | 2025 | Korlym |
| Epizyme, INC. | $28.44 | 2021 | |
| Ge Healthcare | $25.28 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.26 | 2019-2020 | |
| Global Blood Therapeutics, INC. | $24.27 | 2020-2022 | |
| Tesaro, INC. | $24.20 | 2019 | |
| Syndax Pharmaceuticals, INC. | $23.47 | 2025 | |
| Servier Pharmaceuticals LLC | $19.48 | 2024 | |
| Tolmar, INC. | $18.08 | 2023 | |
| Acceleron Pharma, INC. | $16.96 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.36 | 2022 | |
| Sun Pharmaceutical Industries INC. | $14.61 | 2023 | Yonsa, Odomzo |
| Beone Medicines USA, INC. | $14.30 | 2025 | Brukinsa |
| Sirtex Medical INC | $13.03 | 2020 |
Drugs and devices associated with these payments
Enhertu $783Reblozyl $732Darzalex $657Keytruda $596Imfinzi $565Nubeqa $524Opdivo $524Tecvayli $471Rybrevant $431Ojjaara $331Talvey $328Jakafi $271Adcetris $264Orserdu $241Vonjo $230Elrexfio $230Jaypirca $226Verzenio $223Erleada $219Ultomiris $213Tukysa $212Padcev $211Vitrakvi $209Stivarga $209Lenvima $206Calquence $202Xtandi $200Fabhalta $198Opdualag $195Orgovyx $190Pluvicto $188Monjuvi $178Braftovi $175Doptelet $175Alunbrig $174Gavreto $171Inlyta $170Mektovi $169Lorbrena $163Venclexta $158Tavalisse $156Rezlidhia $156Epkinly $150Lumakras $148Kisqali $144Fotivda $143Scemblix $141Ibrance $141Rytelo $139Libtayo $138Lynparza $134Fasenra $129Tymlos $125Amvuttra $125Tecentriq $118Talzenna $115Pyrukynd $107Vyloy $104Myrisk $102Alecensa $102Enjaymo $98.34Elahere $97.52Sarclisa $94.38Brukinsa $94.05Besremi $93.55Zepzelca $93.40Inqovi $93.07Lonsurf $93.07Onivyde $90.33Xpovio $84.49Empaveli $84.16Bosulif $83.50Zoladex $81.27Monoferric $80.55Pomalyst $80.42Tagrisso $78.83Polivy $76.38Cabometyx $73.64Poteligeo $73.61Iclusig $73.54Fruzaqla $73.20Ninlaro $71.65Tivdak $68.73Yescarta $68.69Xalkori $68.68Paxlovid $67.21Qinlock $64.38Ayvakit $60.03Bavencio $59.60Imbruvica $57.70Smartvest $56.51Lunsumio $56.17Lutathera $54.34Rozlytrek $51.75Avastin $51.75Jevtana $51.68Beleodaq $50.58Carvykti $50.46Gazyva $49.11Piqray $48.03
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.